Assessment instrument | Reliability | Validity | Responsiveness | Time | Research group | References | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Test–retest | Inter-rater | Intra-rater | Content | Structural | Criterion | ||||||
EORTC QLQ-BN20 | + | + | + | n = 891, brain tumor | Taphoornet al. [27] | ||||||
+* | + | < 10 min | n = 350, glioma, meningioma | Shin and Kim [28] | |||||||
+ | + | + | n = 194, brain tumor | Khoshnevisan et al. [29] | |||||||
+ | + | n = 100, brain tumor | Bunevičius et al. [30] | ||||||||
EORTC QLQ-C30 | +* | − | + | 13–14 (SD 12) min | n = 366, brain tumor | Cheng et al. [31] | |||||
FACT-Br | + | + | + | n = 500, brain tumor | Arli and Gurkan [32] | ||||||
+§ | +†,‡ | + | 5 to 10 min | n = 101, brain tumor | Weitzner et al. [33] | ||||||
+† | + | + | n = 62, metastases in the brain | Thavarajah et al. [34] | |||||||
SF-36 | + | + | n = 277, brain tumor | Bunevičius et al. [30] |